PhaseBio Pharmaceuticals Inc (PHAS)

NASDAQ
0.070
-0.025(-26.21%)
After Hours
0.053
-0.017(-23.966%)
- Real-time Data
  • Volume:
    8,811,099
  • Day's Range:
    0.067 - 0.092
  • 52 wk Range:
    0.067 - 4.080
Unusual Post-Market activity

Post-market activity occurs after regular market hours and can be used to judge market strength and direction. Post-market trading has some risk because of lower liquidity and more volatility than regular sessions.

1 / 3

PHAS Overview

Prev. Close
0.095
Day's Range
0.067-0.092
Revenue
828K
Open
0.081
52 wk Range
0.067-4.08
EPS
-2.12
Volume
8,811,099
Market Cap
2.94M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,544,684.03
P/E Ratio
-0.559
Beta
2.47
1-Year Change
-97.04%
Shares Outstanding
49,858,116
Next Earnings Date
-
What is your sentiment on PhaseBio Pharmaceuticals?
or
Market is currently closed. Voting is open during market hours.

PhaseBio Pharmaceuticals Inc News

PhaseBio Pharmaceuticals Inc Analysis

PhaseBio Pharmaceuticals Inc Company Profile

PhaseBio Pharmaceuticals Inc Company Profile

Employees
60

PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel for cardiovascular diseases. Its lead product candidate is bentracimab (PB2452), a reversal agent for the antiplatelet drug ticagrelor that is in Phase III clinical trial for patients with uncontrolled major or life-threatening bleeding events or in patients requiring urgent or an invasive procedure. The company is also developing PB1046, a vasoactive intestinal peptide analogue for the treatment of pulmonary arterial hypertension; and PB6440 for the treatment of resistant hypertension. The company has a co-development agreement with SFJ Pharmaceuticals X, Ltd. to develop PB2452, a reversal agent for the antiplatelet drug ticagrelor. PhaseBio Pharmaceuticals, Inc. was incorporated in 2002 and is based in Malvern, Pennsylvania. On October 23, 2022, PhaseBio Pharmaceuticals, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • jamani mm sijui kutumia mnanisaidiaje
    0
    • 0.68 aim for -0-
      0
      • Hello? 👀
        1
        • 8.5 aim 17
          4
          • 7.35 aim for 15
            1